🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. biologics treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis

    approved mab active

    1 trial

  2. budesonide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Respiratory Distress Syndrome

    approved small molecule active

    1 trial

  3. budesonide/formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cough Variant Asthma

    approved small molecule active

    1 trial

  4. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

  5. dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Quality of Patients Undergoing TURP

    approved small molecule completed

    1 trial

  6. early enteral nutrition

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Pancreatitis

    approved small molecule completed

    1 trial

  7. fecal microbiota transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    approved small molecule active

    1 trial

  8. first-line scheme+compound kushen injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Colorectal Carcinoma

    approved small molecule active

    1 trial

  9. gabapentin + tramadol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pain

    approved small molecule active

    1 trial

  10. handwashing

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Communicable Diseases

    approved other completed

    1 trial

  11. hydroxyethl starch

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cesarean Section

    approved small molecule completed

    1 trial

  12. intravenous sufentanil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule completed

    1 trial

  13. lamivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Compensated Chronic Hepatitis B

    approved small molecule completed

    1 trial

  14. low-dose rivaroxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  15. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  16. mesenchymal stromal cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    MSC

    approved mab active

    1 trial

  17. midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mechanical Ventilation

    approved small molecule active

    1 trial

  18. mirabegron

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  19. nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST-segment Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  20. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  21. phacoemulsification

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Astigmatism

    approved other active

    1 trial

  22. preoperative 0.5% ropivacaine hydrochloride preoperative

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule completed

    1 trial

  23. propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Sleep Quality

    approved small molecule completed

    1 trial

  24. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Birth

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources